SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-033598
Filing Date
2019-07-02
Accepted
2019-07-02 16:20:43
Documents
6
Period of Report
2019-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv524705_6-k.htm 6-K 25750
2 EXHIBIT 5.1 tv524705_ex5-1.htm EX-5.1 34812
3 EXHIBIT 10.1 tv524705_ex10-1.htm EX-10.1 230736
4 EXHIBIT 10.2 tv524705_ex10-2.htm EX-10.2 93437
5 GRAPHIC image_006.jpg GRAPHIC 3292
6 GRAPHIC image_007.jpg GRAPHIC 3358
  Complete submission text file 0001144204-19-033598.txt   395376
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 19937696
SIC: 2834 Pharmaceutical Preparations